Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment (Apollo)
A Prospective Observational Study Using Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment
Sponsor: Aachen Resonance GmbH
Listed as NCT02539940, this observational or N/A phase trial focuses on Critical Limb Ischemia and Peripheral Artery Disease and remains completed. Sponsored by Aachen Resonance GmbH, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2019 — Apr 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aachen Resonance GmbH
- Jena University Hospital
- Zentrum für Klinische Studien Jena
For direct contact, visit the study record on ClinicalTrials.gov .